Ships from AustraliaBatch-tested research catalogueAustralia Post Standard & Express
CJC-1295 (No DAC) + Ipamorelin Blend 10mg
Research Peptide10mgAdvanced

CJC-1295 (No DAC) + Ipamorelin Blend 10mg

Buy CJC-1295 No DAC + Ipamorelin blend in Australia. Dual-peptide research compound for growth hormone signalling studies with fast shipping.

CJC-1295 (No DAC) 5mg + Ipamorelin 5mgGrowth hormone signalling researchDual-peptide blend for simplified workflowsShort-acting No DAC profilePurity: ≥ 99% (HPLC verified)
Item price$139.99 AUD
Quantity1
Total$139.99 AUD
  • CJC-1295 (No DAC) 5mg + Ipamorelin 5mg
  • Growth hormone signalling research
  • Dual-peptide blend for simplified workflows
  • Short-acting No DAC profile
  • Purity: ≥ 99% (HPLC verified)
  • Lyophilized peptide powder
  • Batch-tested for consistency
  • Lab report available
  • Cold storage recommended
  • Ships from Australia
Research-use-only notice

Not intended for human or veterinary use, consumption, injection, application, diagnosis, treatment, cure, prevention, or therapeutic use.

Back to shop
Product guide

Buy CJC-1295 No DAC + Ipamorelin Australia | GH Peptide – PDA

The CJC-1295 (No DAC) + Ipamorelin Blend 10mg is supplied for research applications focused on growth hormone signalling pathways. Available in Australia with fast dispatch, this dual-peptide format supports controlled and repeatable laboratory workflows.

CJC-1295 No DAC + Ipamorelin Australia

This dual-peptide blend is supplied for research use in Australia, providing a reliable option for laboratories studying growth hormone signalling and receptor activity.

Growth hormone signalling research

CJC-1295 and Ipamorelin are commonly studied for their interaction with growth hormone pathways, making this blend relevant for receptor-binding and signalling research under controlled laboratory conditions.

No DAC variant advantages

The No DAC version of CJC-1295 is characterized by a shorter duration of action, allowing researchers to maintain tighter control over exposure timing and experimental response.

  • Shorter active window
  • Greater control over timing
  • Flexible experimental design

Dual-peptide research format

Combining both peptides into a single vial simplifies preparation and supports consistent workflows across experimental cycles.

  • 5mg / 5mg balanced blend
  • Reduced preparation steps
  • Improved workflow consistency

Quality and formulation

Each vial is lyophilized to maintain stability and support long-term storage under proper laboratory conditions. Batch testing ensures consistency across supply.

  • ≥99% purity (HPLC verified)
  • Lyophilized powder format
  • Batch-tested for consistency
  • Cold storage recommended

Australia-wide shipping

Orders are dispatched from within Australia with fast processing times. Shipping options, including tracked delivery, are displayed during checkout.

Why choose Peptides Direct Australia

Peptides Direct Australia provides a reliable source for research peptides with fast local shipping, consistent product quality, and a streamlined checkout experience.

  • Fast dispatch with tracked Australia Post delivery
  • Secure checkout with clear payment instructions
  • Consistent batch-tested products
  • Research-use-only catalogue with transparent listings
FAQ

Frequently asked questions

Is this CJC-1295 + Ipamorelin blend available in Australia?

Yes, this product is available for research-use purposes and ships Australia-wide.

What is the difference between No DAC and DAC versions?

The No DAC version has a shorter duration of action, allowing for more controlled timing in research environments compared to DAC-bound variants.

What is this blend used for in research?

This blend is commonly studied in laboratory environments for growth hormone signalling and receptor pathway research.

Is this product for human use?

No. This product is supplied strictly for research purposes and is not intended for human or veterinary use.